Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
- PMID: 16625125
- DOI: 10.1097/01.CCM.0000217961.75225.E9
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Abstract
Objective: To determine the prevalence and impact on mortality of delays in initiation of effective antimicrobial therapy from initial onset of recurrent/persistent hypotension of septic shock.
Design: A retrospective cohort study performed between July 1989 and June 2004.
Setting: Fourteen intensive care units (four medical, four surgical, six mixed medical/surgical) and ten hospitals (four academic, six community) in Canada and the United States.
Patients: Medical records of 2,731 adult patients with septic shock.
Interventions: None.
Measurements and main results: The main outcome measure was survival to hospital discharge. Among the 2,154 septic shock patients (78.9% total) who received effective antimicrobial therapy only after the onset of recurrent or persistent hypotension, a strong relationship between the delay in effective antimicrobial initiation and in-hospital mortality was noted (adjusted odds ratio 1.119 [per hour delay], 95% confidence interval 1.103-1.136, p<.0001). Administration of an antimicrobial effective for isolated or suspected pathogens within the first hour of documented hypotension was associated with a survival rate of 79.9%. Each hour of delay in antimicrobial administration over the ensuing 6 hrs was associated with an average decrease in survival of 7.6%. By the second hour after onset of persistent/recurrent hypotension, in-hospital mortality rate was significantly increased relative to receiving therapy within the first hour (odds ratio 1.67; 95% confidence interval, 1.12-2.48). In multivariate analysis (including Acute Physiology and Chronic Health Evaluation II score and therapeutic variables), time to initiation of effective antimicrobial therapy was the single strongest predictor of outcome. Median time to effective antimicrobial therapy was 6 hrs (25-75th percentile, 2.0-15.0 hrs).
Conclusions: Effective antimicrobial administration within the first hour of documented hypotension was associated with increased survival to hospital discharge in adult patients with septic shock. Despite a progressive increase in mortality rate with increasing delays, only 50% of septic shock patients received effective antimicrobial therapy within 6 hrs of documented hypotension.
Comment in
-
Hypotension and mortality in septic shock: the "golden hour".Crit Care Med. 2006 Jun;34(6):1819-20. doi: 10.1097/01.CCM.0000220054.95214.7D. Crit Care Med. 2006. PMID: 16714981 No abstract available.
-
Best evidence in critical care medicine: Early antibiotics and survival from septic shock: it's about time.Can J Anaesth. 2006 Nov;53(11):1157-60. doi: 10.1007/BF03022884. Can J Anaesth. 2006. PMID: 17079643 No abstract available.
-
Compliance with an empirical antimicrobial protocol improves the outcome of complicated intra-abdominal infections: a prospective observational study.Br J Anaesth. 2016 Jul;117(1):66-72. doi: 10.1093/bja/aew117. Br J Anaesth. 2016. PMID: 27317705 Free PMC article.
-
Best evidence in critical care medicine Early antibiotics and survival from septic shock: it's about time.Can J Anaesth. 2006 Nov;53(11):1157-1160. doi: 10.1007/BF03022884. Can J Anaesth. 2006. PMID: 27771913 No abstract available.
Similar articles
-
Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy.Intensive Care Med. 2009 May;35(5):871-81. doi: 10.1007/s00134-008-1367-2. Epub 2008 Dec 9. Intensive Care Med. 2009. PMID: 19066848
-
Activated protein C and septic shock: a propensity-matched cohort study*.Crit Care Med. 2012 Nov;40(11):2974-81. doi: 10.1097/CCM.0b013e31825fd6d9. Crit Care Med. 2012. PMID: 22932397
-
Timing of vasopressor initiation and mortality in septic shock: a cohort study.Crit Care. 2014 May 12;18(3):R97. doi: 10.1186/cc13868. Crit Care. 2014. PMID: 24887489 Free PMC article.
-
An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.Virulence. 2014 Jan 1;5(1):80-97. doi: 10.4161/viru.26913. Epub 2013 Nov 1. Virulence. 2014. PMID: 24184742 Free PMC article. Review.
-
Is the mortality rate for septic shock really decreasing?Curr Opin Crit Care. 2008 Oct;14(5):580-6. doi: 10.1097/MCC.0b013e32830f1e25. Curr Opin Crit Care. 2008. PMID: 18787453 Review.
Cited by
-
Novel fast pathogen diagnosis method for severe pneumonia patients in the intensive care unit: randomized clinical trial.Elife. 2022 Oct 7;11:e79014. doi: 10.7554/eLife.79014. Elife. 2022. PMID: 36205312 Free PMC article. Clinical Trial.
-
Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance.J Infect Dis. 2020 Jul 21;222(Suppl 2):S119-S131. doi: 10.1093/infdis/jiaa221. J Infect Dis. 2020. PMID: 32691833 Free PMC article.
-
Effects of Pharmacist-Led Clinical Pathway/Order Sets on Cancer Patients: A Systematic Review.Front Pharmacol. 2021 May 21;12:617678. doi: 10.3389/fphar.2021.617678. eCollection 2021. Front Pharmacol. 2021. PMID: 34093177 Free PMC article.
-
Serum interleukin-6 in the diagnosis of bacterial infection in cirrhotic patients: A meta-analysis.Medicine (Baltimore). 2016 Oct;95(41):e5127. doi: 10.1097/MD.0000000000005127. Medicine (Baltimore). 2016. PMID: 27741137 Free PMC article. Review.
-
Assessment of the timeliness and robustness for predicting adult sepsis.iScience. 2021 Jan 26;24(2):102106. doi: 10.1016/j.isci.2021.102106. eCollection 2021 Feb 19. iScience. 2021. PMID: 33659874 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical